HCA Healthcare Commits $5 Million to Belmont University's Thomas F. Frist, Jr. College of Medicine
NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced a $5 million gift to the Thomas F. Frist, Jr. College of Medicine at Belmont University to support the Belmont Collaborative for Health Systems Innovation. Half of the gift will create the HCA Healthcare Health Systems Science Endowed Chair, and the other $2.5 million will be used for programmatic support in the Health Systems Science department. HCA Healthcare's endowed chair will be matched by the Johnson Academic Challenge, a matching fund program that will create up to 20 endowed professorships across Belmont's academic programs.
'We are proud to deepen our long-standing connection with Belmont University through this new gift to the Thomas F. Frist, Jr. College of Medicine,' said Sam Hazen, CEO of HCA Healthcare. 'We believe it's vital to invest in those who will shape the future of healthcare, and it is an honor to support the next generation of medical students at Belmont University as they learn, grow and lead in Nashville.'
The Thomas F. Frist, Jr. College of Medicine welcomed its inaugural class of 50 students in July 2024. Over the course of their four-year M.D. program, students will have the opportunity to complete clinical rotations at HCA Healthcare's TriStar Health facilities, including TriStar Centennial Medical Center, TriStar Skyline Medical Center and TriStar Southern Hills Medical Center, with planned expansion to other local HCA Healthcare hospitals. Core rotations will cover internal medicine, surgery, OB-GYN, pediatrics, psychiatry, neurology and family medicine, with advanced experiences in acting internships, critical care and emergency medicine.
The HCA Healthcare Health Systems Science Endowed Chair will sit within the college's Collaborative for Health Systems Innovation, an initiative dedicated to transforming healthcare delivery through collaborative education, research and design, implementation and scaling of health care systems solutions.
"This transformative gift from HCA Healthcare embodies our shared commitment to health care excellence and innovation," said Belmont University President Dr. Greg Jones. "The support for our Health Systems Science program, complemented by the Johnson Academic Challenge, will significantly enhance our ability to prepare future physicians who understand the complex systems in which health care is delivered. This partnership honors the legacy of Dr. Thomas F. Frist, Jr. and strengthens the historical bonds between our institutions as we work together to shape the future of healthcare education and delivery."
HCA Healthcare and Belmont University have a long history of connection and collaboration. The medical college is named after HCA Healthcare co-founder, Dr. Thomas F. Frist, Jr., who founded the Company in 1968 alongside his father, Dr. Thomas Frist, Sr. and Jack C. Massey, who is also the namesake of Belmont's College of Business. Milton Johnson, who alongside his wife Denice established the Johnson Academic Challenge fund, served as HCA Healthcare's CEO from 2014 to 2018, during which time he also was a member of Belmont's Board of Trustees. Additionally, HCA Healthcare served as the local health advisor for the Oct. 22, 2020 Presidential Debate at Belmont during the height of the COVID-19 pandemic.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 192 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 44 million annual patient encounters to advance science, improve patient care and save lives.
All references to 'Company,' 'HCA' and 'HCA Healthcare' as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Wall Street Still Loves This Stock--Even After It Crashed nearly 18% in a Day
PVH Corp (NYSE:PVH) just got hammereddown nearly 18% at 12.22pm. The selloff came despite a blockbuster year: record gross margins of 59.4%, $600 million in free cash flow, and a 10% operating margin. Non-GAAP EPS for fiscal 2024 came in at a record $11.74, up 10% from last year. The company even returned $500 million to shareholders through buybacks. On paper, these are the kinds of numbers that should get a standing ovation. Instead, investors hit the exits. So what's going on? A few storm clouds are hanging over the 2025 outlook. Management is guiding for flat to slightly higher revenue, and while EPS could rise to $12.75, the road ahead looks bumpier. Freight costs are ticking up, promotions are likely to intensify, and Chinaone of PVH's key marketsis facing a slowdown post-holiday. To make matters worse, PVH was added to China's unreliable entity list by MOFCOM, introducing a new layer of geopolitical risk. Calvin Klein also ran into product development delays, adding short-term margin pressure to the mix. And yetWall Street hasn't given up. The average price target from 13 analysts sits at $98.23, implying a potential 48.9% upside from current levels. GuruFocus places PVH's fair value at $97.10. Brokerage consensus is still Outperform. Underneath the headline drop, there are signals of strength: EBIT surged over 40% in North America, Europe's store traffic picked up in back-to-back quarters, and core product sell-through is improving. This might just be a stock investors don't like right nowbut could end up regretting not buying later. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
PVH Corp (PVH) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
Revenue Growth: Up 2% on both a reported and constant currency basis. Operating Margin: 8.1% within guidance range. Earnings Per Share (EPS): $2.30, slightly ahead of guidance. Gross Margin: 58.6%, a decrease of 280 basis points compared to last year. Inventory Increase: Up 19% compared to Q1 last year. Direct-to-Consumer Revenue: Down 3% both reported and in constant currency. Wholesale Revenue: Up 7% on a constant currency basis, 6% on a reported basis. EMEA Revenue: Up 4% in constant currency. Americas Revenue: Up 7%, driven by high-teens growth in wholesale. Asia Pacific Revenue: Down 11% on a constant currency basis. Licensing Revenue: Down 2% versus last year. SG&A as a Percent of Revenue: 50.5%, a 90 basis point improvement versus last year. Shareholder Returns: Over $550 million returned through share repurchases. Warning! GuruFocus has detected 7 Warning Signs with CIEN. Release Date: June 05, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. PVH Corp (NYSE:PVH) reported a 2% revenue growth, exceeding their guidance, driven by disciplined execution of the PVH+ Plan. The company delivered stronger than expected non-GAAP EPS, also above their guidance. Calvin Klein's innovative product franchise, Icon Cotton Stretch underwear, drove a 25% increase in sales globally. Tommy Hilfiger's strategic product innovations and seasonal collections have led to stronger performance, particularly in Europe. PVH Corp (NYSE:PVH) returned over $550 million to shareholders through share repurchases during the quarter. The company is facing a challenging macroeconomic environment, with decreased consumer sentiment and traffic trends, particularly in North America and China. PVH Corp (NYSE:PVH) experienced operational challenges with Calvin Klein's global product creation, impacting margins. The company is dealing with a more promotional environment, leading to increased discounting and impacting gross margins. Tariffs are expected to have a $65 million unmitigated impact on EBIT for the full year. Inventory levels increased by 19% due to lower than expected demand for basics and essentials. Q: Stefan, you mentioned decreased traffic and increased promotional levels. What gives you confidence that Calvin Klein and Tommy Hilfiger still have good momentum with consumers? A: Stefan Larsson, CEO: Despite the challenging macro environment, where we lean into consumer love for Calvin Klein and Tommy Hilfiger, we see strong results. For example, our new product innovation in Calvin Klein men's underwear drove 25% growth in a major franchise. Similarly, fashion denim grew by 14%. We plan to expand these successful strategies across more of our business. Q: Can you provide an update on the cost-out efforts and whether they are affecting operational stability, particularly for Calvin Klein? A: Stefan Larsson, CEO: The operational challenges at Calvin Klein were due to the integration of global product capabilities, which is crucial for future growth. We are seeing improvements, with significant progress expected by Spring 2026. Zachary Coughlin, CFO, added that cost-saving measures are on track, with 200 basis points of SG&A leverage expected by Q4 2025. Q: How are you addressing the impact of tariffs, and what are your strategies for mitigating these effects? A: Zachary Coughlin, CFO: We have identified $65 million in unmitigated tariff effects. Our mitigation strategies include optimizing sourcing and production costs, strategic discount reductions, and targeted pricing actions where we have pricing power. Our globally diversified revenue base and strong supply chain relationships are key advantages. Q: With the expected promotional environment, how do you plan to make the brand more resilient from a pricing perspective? A: Stefan Larsson, CEO: We are focusing on scaling the impact of PVH+ execution by enhancing product innovation in key categories and increasing marketing investments to drive traffic. For example, Tommy Hilfiger's partnership with Formula One is a strategic move to connect the brand with a growing sport and enhance its lifestyle appeal. Q: Can you elaborate on the gross margin outlook for the second quarter and the back half of the year? A: Zachary Coughlin, CFO: For the full year, gross margins are expected to decrease by approximately 250 basis points, with 50 basis points due to tariffs and 100 basis points from increased promotional activity. We anticipate sequential improvement in Calvin Klein's operational issues and expect to mitigate the tariff impact over time. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
19 minutes ago
- Yahoo
BofA Maintains Hold Rating on PVH Corp. (PVH), Sets $86 PT
In a report released on June 4, BofA analyst Christopher Nardone maintained a Hold rating on PVH Corp. (NYSE:PVH) with a price target of $86.00. The rating update followed the company's release of its fiscal Q1 2025 results on the same day, with revenue growing 2% to $1.984 billion compared to the same period last year. The analyst based the rating on PVH Corp.'s (NYSE:PVH) future outlook and recent financial performance, stating that it reported a minute fall in sales. This was, however, offset by higher SG&A expenses and lower margins, which resulted in a modest EPS beat. The company reported a non-GAAP EPS of $2.30 in fiscal Q1 2025, which surpassed guidance of $2.10 to $2.25. A customer trying on a sports jacket in-store, showcasing the company's sportswear range. Nardone highlighted that while regions such as America and EMEA experienced sales growth, the company's overall performance was negatively impacted by challenges in APAC and licensing. Management decided to lower the EPS guidance for fiscal 2025 to the $10.75 - $11.00 range on a non-GAAP basis compared to a range of $12.40 - $12.75 previously. The analyst reasoned that this drop reflects margin pressure concerns, somewhat influenced by tariffs. PVH Corp. (NYSE:PVH) also reduced EPS guidance for fiscal Q2 2025 to the $1.85 - $2.00 range on a non-GAAP basis. However, Nardone stated that the company has a history of exceeding conservative forecasts. According to the analyst, the valuation appears to mitigate short-term margin challenges through positive sales trends, which supports the Hold rating as the market assesses PVH Corp.'s (NYSE:PVH) potential to drive sales and manage costs. PVH Corp. (NYSE:PVH) is a luxury fashion company that operates Tommy Hilfiger and Calvin Klein brands. While we acknowledge the potential of PVH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
